Screener
ADMA Biologics ADMA Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | Three Months ended June 30, 2026 | Three Months ended June 30, 2025 | Six Months ended June 30, 2026 | Six Months ended June 30, 2025 |
|---|---|---|---|---|
| (In thousands, except share and per share data) | ||||
| REVENUES | $$124,395 | $121,984 | $238,888 | 236,786 |
| Cost of product revenue | 38,118 | 54,757 | 71,861 | 108,463 |
| Gross profit | 86,277 | 67,227 | 167,027 | 128,323 |
| OPERATING EXPENSES: | ||||
| Research and development | 6,014 | 1,031 | 8,611 | 1,858 |
| Plasma center operating expenses | 1,026 | 1,152 | 2,088 | 2,438 |
| Amortization of intangible assets | 55 | 32 | 110 | 57 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's total revenue?
- ADMA Biologics (ADMA) reported total revenue of $124.4M in Q2 2026.
- How has ADMA Biologics's total revenue changed year-over-year?
- ADMA Biologics's total revenue increased by 2.0% year-over-year, from $121.98M to $124.4M.
- What is the long-term trend for ADMA Biologics's total revenue?
- Over 4 years (2021 to 2025), ADMA Biologics's total revenue has grown at a 58.4% compound annual growth rate (CAGR), from $80.94M to $510.17M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about ADMA Biologics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude